natural glp 1 patches reviews GLP-1 are worse than you think (I was wrong) GLP-1 Companion Health Pack Daily

Higher discontinuation rates and lower maintenance doses compared to trials

Clinical studies usually evaluate Retatrutide as a standalone therapy

It's us who are getting dementia at a higher rate

In April 2025, Empower Pharmacy, a large 503B compounding pharmacy in the US, challenged Eli Lillys pharmaceutical exclusivity by filing a petition to invalidate Eli Lillys tirzepatide patent, arguing that the drug is unpatentable due to prior art

For years, most care leaned on a small set of options like minoxidil and finasteride, plus procedures, so the field became focused on optimization rather than entirely new pathways. Immune-mediated hair loss conditions such as alopecia areata (AA) have seen more recent advances, but even here, durable and well-tolerated options remain limited